...
首页> 外文期刊>Proceedings of the National Academy of Sciences of the United States of America >REGULATION OF SODIUM CHANNEL GENE EXPRESSION BY CLASS I ANTIARRHYTHMIC DRUGS AND N - 3 POLYUNSATURATED FATTY ACIDS IN CULTURED NEONATAL RAT CARDIAC MYOCYTES
【24h】

REGULATION OF SODIUM CHANNEL GENE EXPRESSION BY CLASS I ANTIARRHYTHMIC DRUGS AND N - 3 POLYUNSATURATED FATTY ACIDS IN CULTURED NEONATAL RAT CARDIAC MYOCYTES

机译:I类抗心律失常药物和N-3多不饱和脂肪酸在培养的新生大鼠心肌中调节钠通道基因的表达。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Previous studies have shown that chronic administration of class I antiarrhythmic drugs, which have definite inhibitory action on the fast Na+ channel, result in up-regulation of cardiac Na+ channel expression, and suggest that this effect may contribute to their deleterious effects during chronic administration, Recent studies have shown that the antiarrhythmic effects of free n - 3 polyunsaturated fatty acids (PUFA) are associated with an inhibition of the Na+ channel, Whether the PUPA when used chronically will mimic the effect of the class I drugs on the expression of the Na+ channel is not known. To answer this question, we determined the level of mRNA encoding cardiac Na+ channels and the number of the Na+ channels per cell in cultured neonatal rat cardiac myocytes after supplementation of the cells with the n - 3 PUFA eicosapentaenoic acid (EPA), the class I drug mexiletine, or both EPA and mexiletine for 3-4 days, The number of sodium channels was assessed with a radioligand binding assay using the sodium channel-specific toxin [H-3]batrachotoxinin benzoate ([H-3]BTXB), The supplementation of myocytes with mexiletine (20 mu M) induced a 4-fold increase in [H-3]BTXB specific binding to the cells, In contrast, chronic treatment with EPA (20 mu M) alone did not significantly affect [H-3]BTXB binding. However, the combination of EPA with mexiletine produced a 40-50% reduction in the [H-3]BTXB binding, compared with that seen with mexiletine alone, RNA isolated from cardiac myocytes was probed with a 2.5-kb cRNA transcribed with T7 RNA polymerase from the clone Na-8.4, which encodes nucleotides 3361-5868 of the alpha-subunit of the R(IIA) sodium channel subtype, The changes in the level of mRNA encoding sodium channel Lu-subunit were correlated with comparable changes in sodium channel number in the cultured myocytes, indicating that regulation of transcription of mRNA or its processing and stability is primarily responsible for the regulation of sodium channel number. These data demonstrate that chronic EPA treatment not only does not up-regulate the cardiac sodium channel expression but also reduces the mexiletine-induced increase in the cardiac sodium channel expression. [References: 31]
机译:先前的研究表明,长期服用I类抗心律不齐药物对Na +快速通道具有明确的抑制作用,会导致心脏Na +通道表达上调,并表明这种作用可能会在长期服用期间对其有害作用产生影响,近期研究表明,游离n-3多不饱和脂肪酸(PUFA)的抗心律失常作用与Na +通道的抑制有关。长期使用PUPA是否会模仿I类药物对Na +表达的影响频道未知。为了回答这个问题,我们在培养的新生大鼠心肌细胞中添加了n-3 PUFA二十碳五烯酸(EPA),确定了编码心脏Na +通道的mRNA的水平以及每个细胞中Na +通道的数量。药物美西律,或同时使用EPA和美西律,持续3-4天。使用钠离子通道特异性毒素[H-3] bachochotoxinin benzoate([H-3] BTXB),通过放射性配体结合测定法评估钠离子通道的数量,用美西律(20μM)补充心肌细胞会导致[H-3] BTXB特异性结合细胞增加4倍,相反,单独使用EPA(20μM)进行的慢性治疗并没有显着影响[H-3 ] BTXB绑定。然而,EPA与美西律的组合使[H-3] BTXB结合减少40-50%,与单独美西律观察到的相比,用从T7 RNA转录的2.5kb cRNA探测从心肌细胞分离的RNA来自克隆Na-8.4的聚合酶,其编码R(IIA)钠通道亚型的α-亚基的核苷酸3361-5868,编码钠通道Lu-亚基的mRNA的水平变化与钠通道的可比变化相关在培养的心肌细胞中的数目,表明对mRNA转录的调控或其加工和稳定性主要是对钠通道数的调控。这些数据证明,慢性EPA治疗不仅不上调心脏钠通道的表达,而且减少了美西律汀诱导的心脏钠通道表达的增加。 [参考:31]

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号